

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.62773413 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.62773413 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.15257040 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.15257040 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.80085306 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.08886798 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.08886798 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.08886798 |
| 9 | kynurenine metabolic process (GO:0070189) | 5.82642774 |
| 10 | bile acid biosynthetic process (GO:0006699) | 5.80002575 |
| 11 | tryptophan metabolic process (GO:0006568) | 5.72626901 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.70442361 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.38293646 |
| 14 | urea cycle (GO:0000050) | 5.33193146 |
| 15 | urea metabolic process (GO:0019627) | 5.33193146 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.22655742 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.22062999 |
| 18 | complement activation, alternative pathway (GO:0006957) | 5.10729599 |
| 19 | regulation of protein activation cascade (GO:2000257) | 5.04929712 |
| 20 | protein carboxylation (GO:0018214) | 5.01657264 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.01657264 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.01202083 |
| 23 | regulation of fibrinolysis (GO:0051917) | 4.97969740 |
| 24 | bile acid metabolic process (GO:0008206) | 4.97049587 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 4.92823329 |
| 26 | aromatic amino acid family metabolic process (GO:0009072) | 4.91686828 |
| 27 | cysteine metabolic process (GO:0006534) | 4.91564471 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 4.88663003 |
| 29 | tyrosine metabolic process (GO:0006570) | 4.75147406 |
| 30 | regulation of complement activation (GO:0030449) | 4.72249958 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 4.66811106 |
| 32 | homocysteine metabolic process (GO:0050667) | 4.64683720 |
| 33 | behavioral response to nicotine (GO:0035095) | 4.59265275 |
| 34 | reverse cholesterol transport (GO:0043691) | 4.58561309 |
| 35 | alpha-amino acid catabolic process (GO:1901606) | 4.51744296 |
| 36 | coenzyme catabolic process (GO:0009109) | 4.50045855 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.49047634 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.46219859 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.45724363 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 4.45724363 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.45724363 |
| 42 | L-fucose catabolic process (GO:0042355) | 4.43496300 |
| 43 | fucose catabolic process (GO:0019317) | 4.43496300 |
| 44 | L-fucose metabolic process (GO:0042354) | 4.43496300 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.42010682 |
| 46 | indolalkylamine metabolic process (GO:0006586) | 4.41748331 |
| 47 | amine catabolic process (GO:0009310) | 4.38221894 |
| 48 | cellular biogenic amine catabolic process (GO:0042402) | 4.38221894 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.36786600 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.36786600 |
| 51 | glutamate metabolic process (GO:0006536) | 4.27090218 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 4.25123754 |
| 53 | phospholipid efflux (GO:0033700) | 4.24577362 |
| 54 | bile acid and bile salt transport (GO:0015721) | 4.20382557 |
| 55 | imidazole-containing compound metabolic process (GO:0052803) | 4.19975553 |
| 56 | cellular amino acid catabolic process (GO:0009063) | 4.15748112 |
| 57 | cellular ketone body metabolic process (GO:0046950) | 4.14302079 |
| 58 | cholesterol efflux (GO:0033344) | 4.13839370 |
| 59 | lysine catabolic process (GO:0006554) | 4.10496716 |
| 60 | lysine metabolic process (GO:0006553) | 4.10496716 |
| 61 | negative regulation of sterol transport (GO:0032372) | 4.05834047 |
| 62 | negative regulation of cholesterol transport (GO:0032375) | 4.05834047 |
| 63 | benzene-containing compound metabolic process (GO:0042537) | 4.02424178 |
| 64 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.01538869 |
| 65 | cellular glucuronidation (GO:0052695) | 4.00350887 |
| 66 | plasma lipoprotein particle clearance (GO:0034381) | 3.97192330 |
| 67 | cellular modified amino acid catabolic process (GO:0042219) | 3.96452733 |
| 68 | drug catabolic process (GO:0042737) | 3.93271930 |
| 69 | ethanol oxidation (GO:0006069) | 3.87553124 |
| 70 | cornea development in camera-type eye (GO:0061303) | 3.87332627 |
| 71 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.85972221 |
| 72 | low-density lipoprotein particle remodeling (GO:0034374) | 3.84620306 |
| 73 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.81627964 |
| 74 | detection of light stimulus involved in visual perception (GO:0050908) | 3.81627964 |
| 75 | regulation of bile acid biosynthetic process (GO:0070857) | 3.79110361 |
| 76 | cofactor catabolic process (GO:0051187) | 3.78242816 |
| 77 | arginine metabolic process (GO:0006525) | 3.77736286 |
| 78 | glycine metabolic process (GO:0006544) | 3.76361625 |
| 79 | serine family amino acid metabolic process (GO:0009069) | 3.74607112 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 3.69507833 |
| 81 | fibrinolysis (GO:0042730) | 3.68487676 |
| 82 | platelet dense granule organization (GO:0060155) | 3.67652462 |
| 83 | NAD biosynthetic process (GO:0009435) | 3.65920708 |
| 84 | response to pheromone (GO:0019236) | 3.65357170 |
| 85 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.63333173 |
| 86 | blood coagulation, intrinsic pathway (GO:0007597) | 3.61794723 |
| 87 | negative regulation of lipase activity (GO:0060192) | 3.61551639 |
| 88 | short-chain fatty acid metabolic process (GO:0046459) | 3.59873441 |
| 89 | carboxylic acid catabolic process (GO:0046395) | 3.58580737 |
| 90 | organic acid catabolic process (GO:0016054) | 3.58580737 |
| 91 | ketone body metabolic process (GO:1902224) | 3.58452185 |
| 92 | aldehyde catabolic process (GO:0046185) | 3.57844365 |
| 93 | uronic acid metabolic process (GO:0006063) | 3.56579109 |
| 94 | glucuronate metabolic process (GO:0019585) | 3.56579109 |
| 95 | serine family amino acid biosynthetic process (GO:0009070) | 3.55472116 |
| 96 | phospholipid homeostasis (GO:0055091) | 3.55296737 |
| 97 | complement activation, classical pathway (GO:0006958) | 3.54504330 |
| 98 | exogenous drug catabolic process (GO:0042738) | 3.52942841 |
| 99 | complement activation (GO:0006956) | 3.52142738 |
| 100 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.52093444 |
| 101 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.52093444 |
| 102 | cholesterol homeostasis (GO:0042632) | 3.51639788 |
| 103 | protein activation cascade (GO:0072376) | 3.51612259 |
| 104 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.49151683 |
| 105 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.49151683 |
| 106 | acetyl-CoA metabolic process (GO:0006084) | 3.48120369 |
| 107 | opsonization (GO:0008228) | 3.47411771 |
| 108 | sterol homeostasis (GO:0055092) | 3.45363014 |
| 109 | gamma-aminobutyric acid transport (GO:0015812) | 3.42983258 |
| 110 | cytolysis (GO:0019835) | 3.41574073 |
| 111 | negative regulation of protein activation cascade (GO:2000258) | 3.41561353 |
| 112 | DNA deamination (GO:0045006) | 3.23274121 |
| 113 | positive regulation of fatty acid transport (GO:2000193) | 3.22054436 |
| 114 | mannosylation (GO:0097502) | 3.15073526 |
| 115 | respiratory chain complex IV assembly (GO:0008535) | 3.14296076 |
| 116 | regulation of hexokinase activity (GO:1903299) | 3.09349955 |
| 117 | regulation of glucokinase activity (GO:0033131) | 3.09349955 |
| 118 | transepithelial transport (GO:0070633) | 3.05819640 |
| 119 | S-adenosylmethionine metabolic process (GO:0046500) | 3.05611228 |
| 120 | regulation of cilium movement (GO:0003352) | 3.03423556 |
| 121 | sulfation (GO:0051923) | 3.01344910 |
| 122 | photoreceptor cell maintenance (GO:0045494) | 3.00219484 |
| 123 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.98650955 |
| 124 | cellular response to ATP (GO:0071318) | 2.96990406 |
| 125 | auditory receptor cell stereocilium organization (GO:0060088) | 2.95060588 |
| 126 | protein-cofactor linkage (GO:0018065) | 2.94871926 |
| 127 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.89382214 |
| 128 | indole-containing compound metabolic process (GO:0042430) | 2.86495578 |
| 129 | positive regulation of icosanoid secretion (GO:0032305) | 2.84457316 |
| 130 | behavioral response to ethanol (GO:0048149) | 2.83668954 |
| 131 | positive regulation of prostaglandin secretion (GO:0032308) | 2.82067893 |
| 132 | cytochrome complex assembly (GO:0017004) | 2.81680993 |
| 133 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.80870017 |
| 134 | neuronal action potential (GO:0019228) | 2.80026175 |
| 135 | primary amino compound metabolic process (GO:1901160) | 2.77647378 |
| 136 | neuronal action potential propagation (GO:0019227) | 2.77504011 |
| 137 | serotonin metabolic process (GO:0042428) | 2.77153389 |
| 138 | retinal cone cell development (GO:0046549) | 2.75087591 |
| 139 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.74751826 |
| 140 | nucleobase catabolic process (GO:0046113) | 2.74472941 |
| 141 | C4-dicarboxylate transport (GO:0015740) | 2.72133193 |
| 142 | piRNA metabolic process (GO:0034587) | 2.72071187 |
| 143 | axoneme assembly (GO:0035082) | 2.72021178 |
| 144 | somite development (GO:0061053) | 2.71832660 |
| 145 | photoreceptor cell development (GO:0042461) | 2.70862689 |
| 146 | regulation of action potential (GO:0098900) | 2.65393963 |
| 147 | alkaloid metabolic process (GO:0009820) | 2.63017263 |
| 148 | drug metabolic process (GO:0017144) | 2.61471027 |
| 149 | regulation of guanylate cyclase activity (GO:0031282) | 2.61284201 |
| 150 | heme transport (GO:0015886) | 2.60847911 |
| 151 | protein complex biogenesis (GO:0070271) | 2.59656958 |
| 152 | oxidative demethylation (GO:0070989) | 2.59467789 |
| 153 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.58049422 |
| 154 | nephron tubule morphogenesis (GO:0072078) | 2.54077201 |
| 155 | nephron epithelium morphogenesis (GO:0072088) | 2.54077201 |
| 156 | proline transport (GO:0015824) | 2.53690366 |
| 157 | inner ear receptor stereocilium organization (GO:0060122) | 2.53397827 |
| 158 | reflex (GO:0060004) | 2.51900036 |
| 159 | cilium morphogenesis (GO:0060271) | 2.51537100 |
| 160 | parturition (GO:0007567) | 2.50938385 |
| 161 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.50780070 |
| 162 | nonmotile primary cilium assembly (GO:0035058) | 2.49958512 |
| 163 | regulation of microtubule-based movement (GO:0060632) | 2.45739195 |
| 164 | epithelial cilium movement (GO:0003351) | 2.45162357 |
| 165 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.44977606 |
| 166 | protein prenylation (GO:0018342) | 2.43434131 |
| 167 | prenylation (GO:0097354) | 2.43434131 |
| 168 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.43318938 |
| 169 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.43318938 |
| 170 | NADH dehydrogenase complex assembly (GO:0010257) | 2.43318938 |
| 171 | male meiosis I (GO:0007141) | 2.41210006 |
| 172 | positive regulation of organic acid transport (GO:0032892) | 2.40529300 |
| 173 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.39929766 |
| 174 | fucosylation (GO:0036065) | 2.39803509 |
| 175 | dopamine transport (GO:0015872) | 2.39216142 |
| 176 | protein localization to cilium (GO:0061512) | 2.38912480 |
| 177 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.38486282 |
| 178 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.38486282 |
| 179 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.38104993 |
| 180 | quinone biosynthetic process (GO:1901663) | 2.38064920 |
| 181 | eye photoreceptor cell development (GO:0042462) | 2.35876928 |
| 182 | multicellular organism reproduction (GO:0032504) | 2.33165321 |
| 183 | rhodopsin mediated signaling pathway (GO:0016056) | 2.32968646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.86807047 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.04464589 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.08507980 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.81849447 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.60148255 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.68800714 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.00736992 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.72760686 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.68301718 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 3.51296325 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.14415861 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.13819239 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.42361715 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.38544117 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.14419038 |
| 16 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.09544035 |
| 17 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.06466340 |
| 18 | FUS_26573619_Chip-Seq_HEK293_Human | 1.88819538 |
| 19 | EWS_26573619_Chip-Seq_HEK293_Human | 1.88301553 |
| 20 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.83966652 |
| 21 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.83832178 |
| 22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.76621048 |
| 23 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.75660597 |
| 24 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.68436724 |
| 25 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.67490344 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.65405137 |
| 27 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.62360351 |
| 28 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.62360351 |
| 29 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61378863 |
| 30 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.61300491 |
| 31 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.55635721 |
| 32 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.55131157 |
| 33 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.51589424 |
| 34 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.51589424 |
| 35 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.50978798 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46828292 |
| 37 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.45339086 |
| 38 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.45339086 |
| 39 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44981646 |
| 40 | TCF4_23295773_ChIP-Seq_U87_Human | 1.44313077 |
| 41 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.44135850 |
| 42 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.43663098 |
| 43 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.42546514 |
| 44 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.40621319 |
| 45 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.40426340 |
| 46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40181488 |
| 47 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.37578327 |
| 48 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.37572135 |
| 49 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.34720476 |
| 50 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.34676393 |
| 51 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.33640994 |
| 52 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.32044475 |
| 53 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.31940396 |
| 54 | NCOR_22424771_ChIP-Seq_293T_Human | 1.31705360 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30854263 |
| 56 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.28861503 |
| 57 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28861503 |
| 58 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.28096368 |
| 59 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.26525460 |
| 60 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.25733238 |
| 61 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.25556125 |
| 62 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24964486 |
| 63 | AR_20517297_ChIP-Seq_VCAP_Human | 1.22954570 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22209575 |
| 65 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21665503 |
| 66 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21328021 |
| 67 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.20640125 |
| 68 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.20496202 |
| 69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19740614 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19631115 |
| 71 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17990140 |
| 72 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.17247966 |
| 73 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16760692 |
| 74 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11869127 |
| 75 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.11509613 |
| 76 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11300960 |
| 77 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.11293401 |
| 78 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.10116652 |
| 79 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09979548 |
| 80 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.08995350 |
| 81 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08244241 |
| 82 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07910243 |
| 83 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.07582795 |
| 84 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06869773 |
| 85 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06175094 |
| 86 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.05839241 |
| 87 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.04052168 |
| 88 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03279118 |
| 89 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02065619 |
| 90 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.00748427 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00475721 |
| 92 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.99294275 |
| 93 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93909204 |
| 94 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.93523631 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91851365 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91851365 |
| 97 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87954050 |
| 98 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.86255026 |
| 99 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84679902 |
| 100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82812007 |
| 101 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.79888818 |
| 102 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.79126362 |
| 103 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.79015248 |
| 104 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78230587 |
| 105 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.77975598 |
| 106 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77028220 |
| 107 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.76330591 |
| 108 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.76217083 |
| 109 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.75487762 |
| 110 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.75226136 |
| 111 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73320058 |
| 112 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.72038879 |
| 113 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.71717640 |
| 114 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.71431528 |
| 115 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70842981 |
| 116 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.70384096 |
| 117 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.69749360 |
| 118 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.69525254 |
| 119 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.69480068 |
| 120 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.68938416 |
| 121 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.68572686 |
| 122 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.67981712 |
| 123 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.67696337 |
| 124 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.67368379 |
| 125 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.67169628 |
| 126 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.66923556 |
| 127 | CBP_21632823_ChIP-Seq_H3396_Human | 0.66632401 |
| 128 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.66376840 |
| 129 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.66166500 |
| 130 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.66110739 |
| 131 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.65629727 |
| 132 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.65525289 |
| 133 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.64219098 |
| 134 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.62235843 |
| 135 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.61893478 |
| 136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.61477219 |
| 137 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.60980293 |
| 138 | P300_19829295_ChIP-Seq_ESCs_Human | 0.60168752 |
| 139 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59847412 |
| 140 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.58908434 |
| 141 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.58783205 |
| 142 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.58581073 |
| 143 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.58439777 |
| 144 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.58277217 |
| 145 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.58233015 |
| 146 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58123370 |
| 147 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.57981161 |
| 148 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.57889494 |
| 149 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.57451220 |
| 150 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.57398024 |
| 151 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.56744957 |
| 152 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.56556432 |
| 153 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.56022029 |
| 154 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.55992605 |
| 155 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.55186252 |
| 156 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.55142551 |
| 157 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.54673564 |
| 158 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.54673564 |
| 159 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.54354622 |
| 160 | STAT3_23295773_ChIP-Seq_U87_Human | 0.54000911 |
| 161 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.53948026 |
| 162 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.53695046 |
| 163 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.53584615 |
| 164 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.53426848 |
| 165 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.53419619 |
| 166 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.53341720 |
| 167 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.53316859 |
| 168 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.53269834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.14503191 |
| 2 | MP0005360_urolithiasis | 6.99808973 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.38835961 |
| 4 | MP0005365_abnormal_bile_salt | 6.07577519 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.00203731 |
| 6 | MP0003252_abnormal_bile_duct | 3.89791001 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.86106155 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.41759681 |
| 9 | MP0003195_calcinosis | 3.35719798 |
| 10 | MP0005083_abnormal_biliary_tract | 3.33689900 |
| 11 | MP0006292_abnormal_olfactory_placode | 2.92674856 |
| 12 | MP0008877_abnormal_DNA_methylation | 2.81061745 |
| 13 | MP0009840_abnormal_foam_cell | 2.80955917 |
| 14 | MP0005332_abnormal_amino_acid | 2.69906113 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.58165842 |
| 16 | MP0003787_abnormal_imprinting | 2.54118736 |
| 17 | MP0003880_abnormal_central_pattern | 2.24580858 |
| 18 | MP0004885_abnormal_endolymph | 2.24474069 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.21310629 |
| 20 | MP0003868_abnormal_feces_composition | 2.13379214 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.10701334 |
| 22 | MP0002638_abnormal_pupillary_reflex | 2.10450091 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 2.07215165 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.99743364 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.99157338 |
| 26 | MP0000609_abnormal_liver_physiology | 1.93864214 |
| 27 | MP0002736_abnormal_nociception_after | 1.87920348 |
| 28 | MP0002938_white_spotting | 1.80333256 |
| 29 | MP0001986_abnormal_taste_sensitivity | 1.79654636 |
| 30 | MP0002102_abnormal_ear_morphology | 1.78701769 |
| 31 | MP0001764_abnormal_homeostasis | 1.60210952 |
| 32 | MP0008789_abnormal_olfactory_epithelium | 1.60027730 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.59839658 |
| 34 | MP0000372_irregular_coat_pigmentation | 1.55444389 |
| 35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54121763 |
| 36 | MP0009697_abnormal_copulation | 1.53815102 |
| 37 | MP0000427_abnormal_hair_cycle | 1.47596970 |
| 38 | MP0001485_abnormal_pinna_reflex | 1.45139215 |
| 39 | MP0005451_abnormal_body_composition | 1.44583032 |
| 40 | MP0002837_dystrophic_cardiac_calcinosis | 1.43461099 |
| 41 | MP0005645_abnormal_hypothalamus_physiol | 1.39695063 |
| 42 | MP0006072_abnormal_retinal_apoptosis | 1.39330200 |
| 43 | MP0005253_abnormal_eye_physiology | 1.38029707 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.37528073 |
| 45 | MP0010386_abnormal_urinary_bladder | 1.34765302 |
| 46 | MP0004742_abnormal_vestibular_system | 1.31461427 |
| 47 | MP0002064_seizures | 1.30856890 |
| 48 | MP0005647_abnormal_sex_gland | 1.30760156 |
| 49 | MP0003283_abnormal_digestive_organ | 1.29799927 |
| 50 | MP0002234_abnormal_pharynx_morphology | 1.29576804 |
| 51 | MP0000631_abnormal_neuroendocrine_gland | 1.25822955 |
| 52 | MP0002735_abnormal_chemical_nociception | 1.25799344 |
| 53 | MP0003011_delayed_dark_adaptation | 1.22851229 |
| 54 | MP0002572_abnormal_emotion/affect_behav | 1.21293954 |
| 55 | MP0002557_abnormal_social/conspecific_i | 1.20683441 |
| 56 | MP0006276_abnormal_autonomic_nervous | 1.18366886 |
| 57 | MP0003690_abnormal_glial_cell | 1.18004045 |
| 58 | MP0003136_yellow_coat_color | 1.16817083 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.15587560 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.15223696 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.13822235 |
| 62 | MP0001970_abnormal_pain_threshold | 1.12831657 |
| 63 | MP0009643_abnormal_urine_homeostasis | 1.10481385 |
| 64 | MP0000538_abnormal_urinary_bladder | 1.10395341 |
| 65 | MP0000604_amyloidosis | 1.10118351 |
| 66 | MP0002733_abnormal_thermal_nociception | 1.08855750 |
| 67 | MP0004133_heterotaxia | 1.08630863 |
| 68 | MP0003646_muscle_fatigue | 1.06956815 |
| 69 | MP0009764_decreased_sensitivity_to | 1.06894958 |
| 70 | MP0005499_abnormal_olfactory_system | 1.06605342 |
| 71 | MP0005394_taste/olfaction_phenotype | 1.06605342 |
| 72 | MP0005410_abnormal_fertilization | 1.02965240 |
| 73 | MP0002822_catalepsy | 1.02748907 |
| 74 | MP0002909_abnormal_adrenal_gland | 1.01603113 |
| 75 | MP0003186_abnormal_redox_activity | 1.01429818 |
| 76 | MP0002160_abnormal_reproductive_system | 1.01354160 |
| 77 | MP0005386_behavior/neurological_phenoty | 0.99036528 |
| 78 | MP0004924_abnormal_behavior | 0.99036528 |
| 79 | MP0002734_abnormal_mechanical_nocicepti | 0.97409212 |
| 80 | MP0005389_reproductive_system_phenotype | 0.97309546 |
| 81 | MP0003329_amyloid_beta_deposits | 0.96815392 |
| 82 | MP0000383_abnormal_hair_follicle | 0.95904367 |
| 83 | MP0002067_abnormal_sensory_capabilities | 0.95576563 |
| 84 | MP0005636_abnormal_mineral_homeostasis | 0.95309309 |
| 85 | MP0002254_reproductive_system_inflammat | 0.94021451 |
| 86 | MP0000598_abnormal_liver_morphology | 0.91828537 |
| 87 | MP0005084_abnormal_gallbladder_morpholo | 0.91271504 |
| 88 | MP0003635_abnormal_synaptic_transmissio | 0.91225306 |
| 89 | MP0000647_abnormal_sebaceous_gland | 0.90029167 |
| 90 | MP0005535_abnormal_body_temperature | 0.89216560 |
| 91 | MP0009763_increased_sensitivity_to | 0.88426590 |
| 92 | MP0001324_abnormal_eye_pigmentation | 0.87511314 |
| 93 | MP0002653_abnormal_ependyma_morphology | 0.87387262 |
| 94 | MP0003878_abnormal_ear_physiology | 0.87230607 |
| 95 | MP0005377_hearing/vestibular/ear_phenot | 0.87230607 |
| 96 | MP0003121_genomic_imprinting | 0.87219755 |
| 97 | MP0000639_abnormal_adrenal_gland | 0.85770315 |
| 98 | MP0005408_hypopigmentation | 0.85492533 |
| 99 | MP0002095_abnormal_skin_pigmentation | 0.85475755 |
| 100 | MP0002063_abnormal_learning/memory/cond | 0.85282592 |
| 101 | MP0001963_abnormal_hearing_physiology | 0.85132347 |
| 102 | MP0002078_abnormal_glucose_homeostasis | 0.83465726 |
| 103 | MP0009642_abnormal_blood_homeostasis | 0.82821838 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.82038324 |
| 105 | MP0000026_abnormal_inner_ear | 0.80517482 |
| 106 | MP0005195_abnormal_posterior_eye | 0.80053279 |
| 107 | MP0005670_abnormal_white_adipose | 0.79141893 |
| 108 | MP0001661_extended_life_span | 0.78512287 |
| 109 | MP0000613_abnormal_salivary_gland | 0.75450342 |
| 110 | MP0005220_abnormal_exocrine_pancreas | 0.73662728 |
| 111 | MP0008469_abnormal_protein_level | 0.72575698 |
| 112 | MP0004381_abnormal_hair_follicle | 0.70565396 |
| 113 | MP0004043_abnormal_pH_regulation | 0.70509420 |
| 114 | MP0005376_homeostasis/metabolism_phenot | 0.68956722 |
| 115 | MP0005334_abnormal_fat_pad | 0.67177405 |
| 116 | MP0006036_abnormal_mitochondrial_physio | 0.64824194 |
| 117 | MP0000920_abnormal_myelination | 0.63098310 |
| 118 | MP0005646_abnormal_pituitary_gland | 0.62662963 |
| 119 | MP0008874_decreased_physiological_sensi | 0.62437771 |
| 120 | MP0004142_abnormal_muscle_tone | 0.62136338 |
| 121 | MP0002971_abnormal_brown_adipose | 0.60752854 |
| 122 | MP0008872_abnormal_physiological_respon | 0.57605722 |
| 123 | MP0005448_abnormal_energy_balance | 0.56257444 |
| 124 | MP0010368_abnormal_lymphatic_system | 0.54959984 |
| 125 | MP0003953_abnormal_hormone_level | 0.53517444 |
| 126 | MP0001756_abnormal_urination | 0.50217810 |
| 127 | MP0002928_abnormal_bile_duct | 0.50018824 |
| 128 | MP0004130_abnormal_muscle_cell | 0.48854374 |
| 129 | MP0000579_abnormal_nail_morphology | 0.48521408 |
| 130 | MP0005266_abnormal_metabolism | 0.47995060 |
| 131 | MP0003638_abnormal_response/metabolism_ | 0.47395544 |
| 132 | MP0003632_abnormal_nervous_system | 0.46477170 |
| 133 | MP0003075_altered_response_to | 0.45476237 |
| 134 | MP0006035_abnormal_mitochondrial_morpho | 0.43836859 |
| 135 | MP0000230_abnormal_systemic_arterial | 0.41276929 |
| 136 | MP0003633_abnormal_nervous_system | 0.41276168 |
| 137 | MP0004782_abnormal_surfactant_physiolog | 0.39292395 |
| 138 | MP0005395_other_phenotype | 0.39259624 |
| 139 | MP0005551_abnormal_eye_electrophysiolog | 0.38810104 |
| 140 | MP0000566_synostosis | 0.38723723 |
| 141 | MP0003631_nervous_system_phenotype | 0.38546762 |
| 142 | MP0003724_increased_susceptibility_to | 0.37846181 |
| 143 | MP0002229_neurodegeneration | 0.35886185 |
| 144 | MP0001502_abnormal_circadian_rhythm | 0.34918316 |
| 145 | MP0001501_abnormal_sleep_pattern | 0.34619848 |
| 146 | MP0005248_abnormal_Harderian_gland | 0.34483768 |
| 147 | MP0004147_increased_porphyrin_level | 0.34438934 |
| 148 | MP0001486_abnormal_startle_reflex | 0.33985636 |
| 149 | MP0002090_abnormal_vision | 0.33655855 |
| 150 | MP0002069_abnormal_eating/drinking_beha | 0.33216469 |
| 151 | MP0001765_abnormal_ion_homeostasis | 0.32683747 |
| 152 | MP0005166_decreased_susceptibility_to | 0.32477765 |
| 153 | MP0003718_maternal_effect | 0.32041296 |
| 154 | MP0002272_abnormal_nervous_system | 0.31353376 |
| 155 | MP0009046_muscle_twitch | 0.31344728 |
| 156 | MP0002168_other_aberrant_phenotype | 0.31080285 |
| 157 | MP0006082_CNS_inflammation | 0.30967041 |
| 158 | MP0009745_abnormal_behavioral_response | 0.30621493 |
| 159 | MP0001984_abnormal_olfaction | 0.30614437 |
| 160 | MP0004883_abnormal_blood_vessel | 0.30351858 |
| 161 | MP0008873_increased_physiological_sensi | 0.29947256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.48751483 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.34349575 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.93182495 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.53957617 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.40962775 |
| 6 | Xanthomatosis (HP:0000991) | 5.91282245 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.86955732 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.42627850 |
| 9 | Complement deficiency (HP:0004431) | 5.30007039 |
| 10 | Joint hemorrhage (HP:0005261) | 4.79170646 |
| 11 | Epidermoid cyst (HP:0200040) | 4.52417325 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.39710860 |
| 13 | Abnormality of methionine metabolism (HP:0010901) | 4.32586341 |
| 14 | Hyperammonemia (HP:0001987) | 4.23793666 |
| 15 | Hyperglycinemia (HP:0002154) | 4.21447963 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.21286488 |
| 17 | Fat malabsorption (HP:0002630) | 4.16336740 |
| 18 | Pancreatic cysts (HP:0001737) | 4.15001521 |
| 19 | Ketosis (HP:0001946) | 4.12369836 |
| 20 | Conjugated hyperbilirubinemia (HP:0002908) | 4.11959509 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.10893165 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.08075544 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.07000783 |
| 24 | Abnormality of midbrain morphology (HP:0002418) | 3.89738318 |
| 25 | Molar tooth sign on MRI (HP:0002419) | 3.89738318 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.89626359 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 3.88616804 |
| 28 | Congenital stationary night blindness (HP:0007642) | 3.76929722 |
| 29 | Abnormality of complement system (HP:0005339) | 3.74258294 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.71107748 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 3.71107748 |
| 32 | Pancreatic fibrosis (HP:0100732) | 3.67731750 |
| 33 | Hyperglycinuria (HP:0003108) | 3.61307723 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.60892096 |
| 35 | Hypoglycemic coma (HP:0001325) | 3.60658783 |
| 36 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.50216698 |
| 37 | Abnormality of the renal cortex (HP:0011035) | 3.48684499 |
| 38 | True hermaphroditism (HP:0010459) | 3.47970533 |
| 39 | Hypercholesterolemia (HP:0003124) | 3.36452050 |
| 40 | Hyperbilirubinemia (HP:0002904) | 3.31752671 |
| 41 | Nephronophthisis (HP:0000090) | 3.28285001 |
| 42 | Steatorrhea (HP:0002570) | 3.20230313 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.10738119 |
| 44 | Delayed CNS myelination (HP:0002188) | 3.08446540 |
| 45 | Type II lissencephaly (HP:0007260) | 3.04574073 |
| 46 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.00228593 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 2.98571826 |
| 48 | Ketoacidosis (HP:0001993) | 2.98209230 |
| 49 | Abnormality of the renal medulla (HP:0100957) | 2.94610150 |
| 50 | Abnormality of serum amino acid levels (HP:0003112) | 2.89328090 |
| 51 | Abnormality of nucleobase metabolism (HP:0010932) | 2.87955766 |
| 52 | Attenuation of retinal blood vessels (HP:0007843) | 2.85831213 |
| 53 | Hypoglycemic seizures (HP:0002173) | 2.77020873 |
| 54 | Spontaneous abortion (HP:0005268) | 2.74992038 |
| 55 | Chronic hepatic failure (HP:0100626) | 2.72401636 |
| 56 | Vascular calcification (HP:0004934) | 2.72280385 |
| 57 | Skin nodule (HP:0200036) | 2.71801437 |
| 58 | Myocardial infarction (HP:0001658) | 2.69267259 |
| 59 | Abnormality of alanine metabolism (HP:0010916) | 2.67013739 |
| 60 | Hyperalaninemia (HP:0003348) | 2.67013739 |
| 61 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.67013739 |
| 62 | Hepatocellular carcinoma (HP:0001402) | 2.66782265 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.66226481 |
| 64 | Medial flaring of the eyebrow (HP:0010747) | 2.65072462 |
| 65 | Metabolic acidosis (HP:0001942) | 2.64281261 |
| 66 | Acanthocytosis (HP:0001927) | 2.60404287 |
| 67 | Gaze-evoked nystagmus (HP:0000640) | 2.59930081 |
| 68 | Decreased central vision (HP:0007663) | 2.59444489 |
| 69 | Abnormality of purine metabolism (HP:0004352) | 2.56825300 |
| 70 | Abnormal gallbladder morphology (HP:0012437) | 2.54834172 |
| 71 | Abnormal drinking behavior (HP:0030082) | 2.52503941 |
| 72 | Polydipsia (HP:0001959) | 2.52503941 |
| 73 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.48463406 |
| 74 | Cystic liver disease (HP:0006706) | 2.45934178 |
| 75 | Lethargy (HP:0001254) | 2.42113101 |
| 76 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.40833661 |
| 77 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.40377656 |
| 78 | Hypoplasia of the fovea (HP:0007750) | 2.40377656 |
| 79 | Gout (HP:0001997) | 2.39030119 |
| 80 | Cholelithiasis (HP:0001081) | 2.37862185 |
| 81 | Abolished electroretinogram (ERG) (HP:0000550) | 2.37439548 |
| 82 | Neonatal onset (HP:0003623) | 2.35051249 |
| 83 | Cardiovascular calcification (HP:0011915) | 2.34426346 |
| 84 | Mitral stenosis (HP:0001718) | 2.34125922 |
| 85 | Glomerulonephritis (HP:0000099) | 2.34118693 |
| 86 | Abnormal gallbladder physiology (HP:0012438) | 2.33904782 |
| 87 | Cholecystitis (HP:0001082) | 2.33904782 |
| 88 | Abnormality of vitamin B metabolism (HP:0004340) | 2.32172632 |
| 89 | Dicarboxylic aciduria (HP:0003215) | 2.31134811 |
| 90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.31134811 |
| 91 | Pendular nystagmus (HP:0012043) | 2.30758657 |
| 92 | Enlarged kidneys (HP:0000105) | 2.29793586 |
| 93 | Irritability (HP:0000737) | 2.29348586 |
| 94 | Amyloidosis (HP:0011034) | 2.29031857 |
| 95 | Cerebral edema (HP:0002181) | 2.28014136 |
| 96 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.27384523 |
| 97 | Tubular atrophy (HP:0000092) | 2.26560103 |
| 98 | Hypophosphatemic rickets (HP:0004912) | 2.23697968 |
| 99 | Hypothermia (HP:0002045) | 2.23545798 |
| 100 | Polyuria (HP:0000103) | 2.21086022 |
| 101 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.18354683 |
| 102 | Inability to walk (HP:0002540) | 2.18330582 |
| 103 | Alkalosis (HP:0001948) | 2.16887515 |
| 104 | Gingival bleeding (HP:0000225) | 2.14755341 |
| 105 | 3-Methylglutaconic aciduria (HP:0003535) | 2.14750900 |
| 106 | Decreased circulating renin level (HP:0003351) | 2.14264750 |
| 107 | Stomach cancer (HP:0012126) | 2.11303675 |
| 108 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.11098725 |
| 109 | Status epilepticus (HP:0002133) | 2.10956268 |
| 110 | Abnormality of urine glucose concentration (HP:0011016) | 2.09893886 |
| 111 | Glycosuria (HP:0003076) | 2.09893886 |
| 112 | Cerebellar dysplasia (HP:0007033) | 2.09441199 |
| 113 | Opisthotonus (HP:0002179) | 2.09095788 |
| 114 | Rickets (HP:0002748) | 2.09030079 |
| 115 | Increased CSF lactate (HP:0002490) | 2.07800675 |
| 116 | Pancreatitis (HP:0001733) | 2.07461801 |
| 117 | Brushfield spots (HP:0001088) | 2.07418533 |
| 118 | Type I transferrin isoform profile (HP:0003642) | 2.06191263 |
| 119 | Methylmalonic aciduria (HP:0012120) | 2.05998257 |
| 120 | Optic nerve hypoplasia (HP:0000609) | 2.05656645 |
| 121 | Gait imbalance (HP:0002141) | 2.04792544 |
| 122 | Abnormality of the fovea (HP:0000493) | 2.04275321 |
| 123 | Bile duct proliferation (HP:0001408) | 2.03724967 |
| 124 | Abnormal biliary tract physiology (HP:0012439) | 2.03724967 |
| 125 | Keratoconus (HP:0000563) | 2.03586899 |
| 126 | Increased corneal curvature (HP:0100692) | 2.03586899 |
| 127 | Menorrhagia (HP:0000132) | 2.03501214 |
| 128 | Lissencephaly (HP:0001339) | 2.03471954 |
| 129 | Proximal tubulopathy (HP:0000114) | 2.02457295 |
| 130 | Acute encephalopathy (HP:0006846) | 2.02239994 |
| 131 | Sensorimotor neuropathy (HP:0007141) | 2.02121673 |
| 132 | Abnormality of the gallbladder (HP:0005264) | 2.02020734 |
| 133 | Methylmalonic acidemia (HP:0002912) | 2.01886244 |
| 134 | Hepatic necrosis (HP:0002605) | 2.01226349 |
| 135 | Abnormal urine output (HP:0012590) | 1.99822216 |
| 136 | Metabolic alkalosis (HP:0200114) | 1.99780527 |
| 137 | Abnormality of macular pigmentation (HP:0008002) | 1.99668821 |
| 138 | Acute necrotizing encephalopathy (HP:0006965) | 1.99422500 |
| 139 | Mitochondrial inheritance (HP:0001427) | 1.99123621 |
| 140 | Hypomagnesemia (HP:0002917) | 1.99096819 |
| 141 | Late onset (HP:0003584) | 1.97395308 |
| 142 | Renal cortical cysts (HP:0000803) | 1.97145350 |
| 143 | Congenital sensorineural hearing impairment (HP:0008527) | 1.97095008 |
| 144 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.96854592 |
| 145 | Sclerocornea (HP:0000647) | 1.96702380 |
| 146 | Poikilocytosis (HP:0004447) | 1.96578732 |
| 147 | Congenital primary aphakia (HP:0007707) | 1.96269678 |
| 148 | Furrowed tongue (HP:0000221) | 1.95688464 |
| 149 | Symptomatic seizures (HP:0011145) | 1.94650077 |
| 150 | Vomiting (HP:0002013) | 1.94072995 |
| 151 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.93146793 |
| 152 | Spastic diplegia (HP:0001264) | 1.92555772 |
| 153 | Broad-based gait (HP:0002136) | 1.92531121 |
| 154 | Confusion (HP:0001289) | 1.90150262 |
| 155 | Progressive inability to walk (HP:0002505) | 1.90034692 |
| 156 | Abnormality of the labia minora (HP:0012880) | 1.89767899 |
| 157 | Hypoplasia of the pons (HP:0012110) | 1.87772696 |
| 158 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.87455696 |
| 159 | Optic disc pallor (HP:0000543) | 1.86740838 |
| 160 | Hemiparesis (HP:0001269) | 1.86430048 |
| 161 | Hypoproteinemia (HP:0003075) | 1.86189879 |
| 162 | Fair hair (HP:0002286) | 1.86129081 |
| 163 | Large for gestational age (HP:0001520) | 1.86070140 |
| 164 | Progressive macrocephaly (HP:0004481) | 1.85848242 |
| 165 | Abnormality of the pons (HP:0007361) | 1.85799497 |
| 166 | Abnormality of proline metabolism (HP:0010907) | 1.85704465 |
| 167 | Hydroxyprolinuria (HP:0003080) | 1.85704465 |
| 168 | Hepatocellular necrosis (HP:0001404) | 1.85242970 |
| 169 | Congenital hepatic fibrosis (HP:0002612) | 1.85094565 |
| 170 | Malnutrition (HP:0004395) | 1.84819539 |
| 171 | Disproportionate short-trunk short stature (HP:0003521) | 1.83978178 |
| 172 | Esophageal varix (HP:0002040) | 1.83754305 |
| 173 | Abnormality of renal excretion (HP:0011036) | 1.82303012 |
| 174 | Progressive cerebellar ataxia (HP:0002073) | 1.82215206 |
| 175 | Hemorrhage of the eye (HP:0011885) | 1.81836330 |
| 176 | Febrile seizures (HP:0002373) | 1.81714957 |
| 177 | Abnormality of vitamin metabolism (HP:0100508) | 1.81034280 |
| 178 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80848205 |
| 179 | Nephrogenic diabetes insipidus (HP:0009806) | 1.78383769 |
| 180 | Abnormal glycosylation (HP:0012345) | 1.77700986 |
| 181 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.77700986 |
| 182 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.77700986 |
| 183 | Abnormal protein glycosylation (HP:0012346) | 1.77700986 |
| 184 | Intestinal atresia (HP:0011100) | 1.76947643 |
| 185 | Generalized aminoaciduria (HP:0002909) | 1.76232071 |
| 186 | Thrombophlebitis (HP:0004418) | 1.73404722 |
| 187 | Elevated hepatic transaminases (HP:0002910) | 1.73092661 |
| 188 | Hyperventilation (HP:0002883) | 1.72729205 |
| 189 | Hyperglycemia (HP:0003074) | 1.72214161 |
| 190 | Abnormality of iron homeostasis (HP:0011031) | 1.70653432 |
| 191 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.70600169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.42396993 |
| 2 | INSRR | 4.18272932 |
| 3 | SIK1 | 3.61546542 |
| 4 | MAP4K2 | 3.23261181 |
| 5 | FGFR4 | 3.22614526 |
| 6 | TAOK3 | 3.10785673 |
| 7 | ERBB4 | 2.79289866 |
| 8 | MAP2K4 | 2.59808226 |
| 9 | ACVR1B | 2.54858460 |
| 10 | BMPR1B | 2.34510410 |
| 11 | ERN1 | 2.22617927 |
| 12 | MAPK13 | 2.18510865 |
| 13 | PINK1 | 2.15804517 |
| 14 | NUAK1 | 2.10762372 |
| 15 | TRIM28 | 2.02990163 |
| 16 | ZAK | 2.02570314 |
| 17 | PIK3CG | 1.95882984 |
| 18 | DAPK2 | 1.90818953 |
| 19 | MAPK15 | 1.69569158 |
| 20 | TLK1 | 1.68584786 |
| 21 | FGFR2 | 1.64052631 |
| 22 | PKN1 | 1.56587452 |
| 23 | MUSK | 1.53298290 |
| 24 | SGK223 | 1.47781085 |
| 25 | SGK494 | 1.47781085 |
| 26 | TXK | 1.46254009 |
| 27 | EPHB1 | 1.45068525 |
| 28 | OXSR1 | 1.37229254 |
| 29 | MAPK11 | 1.34695714 |
| 30 | CAMK2G | 1.32985261 |
| 31 | MST1R | 1.31906126 |
| 32 | MAP3K14 | 1.28439405 |
| 33 | MAP2K7 | 1.22520524 |
| 34 | CASK | 1.22181962 |
| 35 | EPHA4 | 1.21269306 |
| 36 | CAMKK2 | 1.21155721 |
| 37 | PTK2B | 1.19477886 |
| 38 | SGK2 | 1.18305410 |
| 39 | FRK | 1.15706888 |
| 40 | STK39 | 1.14676838 |
| 41 | SGK3 | 1.13755978 |
| 42 | MAP3K7 | 1.09724335 |
| 43 | PRKAA2 | 1.09627563 |
| 44 | IRAK3 | 1.06816438 |
| 45 | STK38L | 1.06427554 |
| 46 | BCR | 1.04158656 |
| 47 | MAP3K4 | 1.01541999 |
| 48 | MKNK2 | 1.01373621 |
| 49 | ADRBK1 | 0.97882741 |
| 50 | PRKCZ | 0.97646150 |
| 51 | PDK2 | 0.97154541 |
| 52 | JAK2 | 0.96218787 |
| 53 | MARK1 | 0.95590697 |
| 54 | LATS1 | 0.93809467 |
| 55 | MET | 0.93639515 |
| 56 | ERBB2 | 0.93390610 |
| 57 | JAK1 | 0.91341142 |
| 58 | IRAK2 | 0.90647849 |
| 59 | PRKCG | 0.90517552 |
| 60 | PIK3CA | 0.89581417 |
| 61 | CDK19 | 0.88808248 |
| 62 | PTK6 | 0.87598802 |
| 63 | MAP3K13 | 0.85489692 |
| 64 | WNK3 | 0.84973800 |
| 65 | CSNK1G1 | 0.83369652 |
| 66 | GRK1 | 0.82977759 |
| 67 | TNIK | 0.82105032 |
| 68 | CSNK1G2 | 0.82100259 |
| 69 | ABL2 | 0.81668682 |
| 70 | IRAK1 | 0.79309399 |
| 71 | TYK2 | 0.79290689 |
| 72 | DYRK2 | 0.78712955 |
| 73 | NTRK2 | 0.77398706 |
| 74 | PLK2 | 0.77339754 |
| 75 | PRKCQ | 0.75137186 |
| 76 | NEK6 | 0.74961977 |
| 77 | MAPK7 | 0.74588301 |
| 78 | PDPK1 | 0.74517123 |
| 79 | BRSK2 | 0.74275487 |
| 80 | MAP3K1 | 0.73396707 |
| 81 | PRKACG | 0.73065442 |
| 82 | NTRK3 | 0.71998563 |
| 83 | WEE1 | 0.71032173 |
| 84 | CAMK1G | 0.70919163 |
| 85 | CSNK1A1L | 0.70600354 |
| 86 | MAPK12 | 0.70306275 |
| 87 | CSNK1G3 | 0.69538843 |
| 88 | NTRK1 | 0.69231017 |
| 89 | STK3 | 0.67829649 |
| 90 | ITK | 0.67559066 |
| 91 | CAMK1D | 0.67261558 |
| 92 | TNK2 | 0.67174145 |
| 93 | MAPK4 | 0.65899722 |
| 94 | WNK4 | 0.64673000 |
| 95 | CAMK2B | 0.64074966 |
| 96 | IKBKB | 0.63540184 |
| 97 | CAMK4 | 0.63287686 |
| 98 | GSK3A | 0.63061670 |
| 99 | PRKCH | 0.62179978 |
| 100 | TEC | 0.60403673 |
| 101 | AKT3 | 0.60331757 |
| 102 | PRKAA1 | 0.60030406 |
| 103 | EIF2AK3 | 0.59800399 |
| 104 | WNK1 | 0.59574981 |
| 105 | FLT3 | 0.59572230 |
| 106 | ERBB3 | 0.58727951 |
| 107 | PRKCI | 0.58472453 |
| 108 | CAMK2A | 0.57795637 |
| 109 | NEK9 | 0.57682470 |
| 110 | TIE1 | 0.53869188 |
| 111 | CAMKK1 | 0.53418947 |
| 112 | MAP2K6 | 0.53170944 |
| 113 | VRK1 | 0.52044249 |
| 114 | CSNK1A1 | 0.51936640 |
| 115 | MINK1 | 0.50901956 |
| 116 | KIT | 0.49827472 |
| 117 | CAMK2D | 0.48817558 |
| 118 | GRK5 | 0.47959758 |
| 119 | MAP2K2 | 0.47746919 |
| 120 | PHKG1 | 0.47237206 |
| 121 | PHKG2 | 0.47237206 |
| 122 | RIPK1 | 0.46962859 |
| 123 | EPHA3 | 0.46789594 |
| 124 | PDK1 | 0.45823453 |
| 125 | RET | 0.45480344 |
| 126 | PRKCA | 0.43912071 |
| 127 | PRKACA | 0.43858369 |
| 128 | IKBKE | 0.43635419 |
| 129 | PRKG1 | 0.43170672 |
| 130 | FER | 0.42709733 |
| 131 | VRK2 | 0.42573750 |
| 132 | TGFBR1 | 0.42303280 |
| 133 | IGF1R | 0.41137984 |
| 134 | PAK3 | 0.40748622 |
| 135 | ADRBK2 | 0.40006000 |
| 136 | CSNK1D | 0.39416997 |
| 137 | RPS6KA5 | 0.38703771 |
| 138 | SYK | 0.38596956 |
| 139 | BMPR2 | 0.38521499 |
| 140 | MST4 | 0.38371385 |
| 141 | CSK | 0.38312749 |
| 142 | MKNK1 | 0.37729645 |
| 143 | STK11 | 0.37600561 |
| 144 | MAP2K1 | 0.37465422 |
| 145 | PRKCE | 0.36858204 |
| 146 | PTK2 | 0.35690789 |
| 147 | PRKACB | 0.34121269 |
| 148 | MAPKAPK5 | 0.33820659 |
| 149 | RPS6KA3 | 0.33609711 |
| 150 | SGK1 | 0.32565122 |
| 151 | MAPKAPK3 | 0.32519428 |
| 152 | CHUK | 0.29458341 |
| 153 | PAK6 | 0.26721979 |
| 154 | EIF2AK2 | 0.26329395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.43996000 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.73320522 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.21729229 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.14192754 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.02251173 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.75938889 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.66160746 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64931598 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49371408 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.36315677 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33677911 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.29412239 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 2.26746324 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24354619 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12954507 |
| 16 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.12681166 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.09802146 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.07948031 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.06713274 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 2.06670091 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.85950716 |
| 22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.85516342 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85128237 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84344670 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77086172 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.73717196 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.72566326 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71923732 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.71724919 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66362232 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.66251080 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63309193 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.62951896 |
| 34 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.56987994 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.56070585 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54968407 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.53581071 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.53149076 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50251378 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.47198939 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45641230 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45035184 |
| 43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.44284821 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.38843282 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.34575974 |
| 46 | Protein export_Homo sapiens_hsa03060 | 1.33398471 |
| 47 | Mineral absorption_Homo sapiens_hsa04978 | 1.29933540 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.29273212 |
| 49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.24517129 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23110905 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17537318 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.16297331 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.15390272 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 1.14443174 |
| 55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.11646300 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.11545196 |
| 57 | Homologous recombination_Homo sapiens_hsa03440 | 1.09009714 |
| 58 | Olfactory transduction_Homo sapiens_hsa04740 | 1.06832386 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06754554 |
| 60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04782363 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01764521 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00503417 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94578470 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.94333354 |
| 65 | RNA polymerase_Homo sapiens_hsa03020 | 0.93865131 |
| 66 | Basal transcription factors_Homo sapiens_hsa03022 | 0.92853199 |
| 67 | Asthma_Homo sapiens_hsa05310 | 0.91400260 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90350429 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89217530 |
| 70 | Morphine addiction_Homo sapiens_hsa05032 | 0.88213322 |
| 71 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84923931 |
| 72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84597810 |
| 73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.84453742 |
| 74 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.81818478 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76444049 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.75387155 |
| 77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71187209 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.68674559 |
| 79 | Circadian entrainment_Homo sapiens_hsa04713 | 0.68403459 |
| 80 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.65916937 |
| 81 | Salivary secretion_Homo sapiens_hsa04970 | 0.64989672 |
| 82 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61915480 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60917721 |
| 84 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57274135 |
| 85 | RNA degradation_Homo sapiens_hsa03018 | 0.56676122 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56376080 |
| 87 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55812120 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54878687 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50622001 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.48443844 |
| 91 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47521870 |
| 92 | Purine metabolism_Homo sapiens_hsa00230 | 0.47508815 |
| 93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46535079 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46118069 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45568678 |
| 96 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.44661443 |
| 97 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.42738077 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41912892 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41004018 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.40304312 |
| 101 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.37968825 |
| 102 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37120381 |
| 103 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.35413788 |
| 104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35246201 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.34858372 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32189767 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30612381 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27739982 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.21802455 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15821723 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.13330938 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.11601943 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07789297 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.07787709 |
| 115 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.07568523 |
| 116 | GABAergic synapse_Homo sapiens_hsa04727 | 0.06836704 |
| 117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.04390857 |
| 118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.01988235 |
| 119 | Taste transduction_Homo sapiens_hsa04742 | -0.1490875 |
| 120 | Cocaine addiction_Homo sapiens_hsa05030 | -0.1487983 |
| 121 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.1426682 |
| 122 | Glutamatergic synapse_Homo sapiens_hsa04724 | -0.1411674 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1369874 |
| 124 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.1321670 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1280120 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1266781 |
| 127 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1147247 |
| 128 | Insulin secretion_Homo sapiens_hsa04911 | -0.1130978 |
| 129 | Nicotine addiction_Homo sapiens_hsa05033 | -0.0888362 |
| 130 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0815447 |
| 131 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0724091 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0658010 |
| 133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0614386 |
| 134 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0563540 |
| 135 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0299688 |
| 136 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0075072 |

